Hims & Hers has delivered strong results and partnerships, but recent Cigna/Novo Nordisk news increases competitive risk and ...

Here's a recap of the week’s most important stories.

Analysts believe each of the stocks below has the potential to at least double in price, although the three firms also carry varying levels of risk.